Pathogenesis of HIV-1 infection within bone marrow cells (Q33334766)

25 July 2017

1 reference

title

Pathogenesis of HIV-1 infection within bone marrow cells (English)

1 reference

25 July 2017

0 references

1 reference

Kulkosky J

1

1 reference

25 July 2017

Bouhamdan M

2

1 reference

25 July 2017

Geist A

3

1 reference

25 July 2017

Nunnari G

4

1 reference

25 July 2017

Phinney DG

5

1 reference

25 July 2017

Pomerantz RJ

6

1 reference

25 July 2017

publication date

1 May 2000

1 reference

25 July 2017

1 reference

25 July 2017

volume

37

1 reference

25 July 2017

issue

5-6

1 reference

25 July 2017

page(s)

497-515

1 reference

Hematologic abnormalities in the acquired immune deficiency syndrome

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Haematologic manifestations of the human immune deficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Pathogenesis of infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Human immunodeficiency virus infection impairs hemopoiesis in long-term bone marrow cultures: nonreversal by nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Chemokine receptors and the molecular basis for human immunodeficiency virus type 1 entry into peripheral hematopoietic stem cells and their progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Characterization of a Human Stromal Cell Line Supporting Hematopoietic Progenitor Cell Proliferation: Effect of HIV Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Macrophages are the major target cell for HIV infection in long-term marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Bone marrow macrophage iron grade and survival of HIV-seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Effect of granulocyte colony-stimulating factor (G-CSF) in human immunodeficiency virus-infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Effect of HIV type 1 Tat protein on butyric acid-induced differentiation in a hematopoietic progenitor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Retrovirus-mediated transfer and long-term expression of HIV type 1 tat gene in murine hematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Opportunistic events and p17 expression in the bone marrow of human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Suppression of in vitro haematopoiesis following human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HIV infection of the BS-1 human stroma cell line: effect on murine hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

In vitro infection of bone marrow-adherent cells by human immunodeficiency virus type 1 (HIV-1) does not alter their ability to support hematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Gamma delta-T cell-receptor-positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Inhibition of marrow CFU-E colony formation from human immunodeficiency virus-infected patients by beta- and gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HIV-1, Vpr and the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Induction of cell differentiation by human immunodeficiency virus 1 vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Complementation of integrase function in HIV-1 virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

Mechanisms of cytopenia in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009058502

10.3109/10428190009058502

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference